ARCHIVES

In Congress: Senate Bill Offers 13% Increase For NCI; house Provides 9%

This article is from The Cancer Letter archive.

Vol. 25 No. 38 | October 8, 1999

Download PDF Visit The Full Archive

Related Articles

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

In Brief: Panel to Meet Jan. 30 In Los Angeles; Fate Of Proposed Urologic Group Depends On Budget

January 10, 1986

Agency Asks GnRH Sponsors To Add Warnings On Labels

October 22, 2010

Funding opportunities listed.

January 2, 2004

DeVita: No Decision Yet On FCRF Award

July 17, 1987

Army Plans Solicitation For Breast Cancer Research Proposals

April 21, 1995